ZMC(SH:600216) Zheng Quan Zhi Xing·2025-08-25 16:35Core Viewpoint - Zhejiang Medicine Co., Ltd. reported a decrease in revenue but a significant increase in net profit for the first half of 2025, indicating improved operational efficiency despite lower sales [1]. Financial Performance - Total assets increased to CNY 14.20 billion, up 2.95% from the previous year [1]. - Revenue for the period was CNY 4.32 billion, a decrease of 1.87% compared to CNY 4.41 billion in the same period last year [1]. - Total profit reached CNY 758.88 million, marking a substantial increase of 126.81% [1]. - Net profit attributable to shareholders was CNY 665.48 million, reflecting a 110.10% increase from CNY 316.74 million in the previous year [1]. - The net cash flow from operating activities was not specified but is a critical indicator of operational health [1]. Shareholder Information - The total number of shareholders as of the report date was 65,531 [1]. - The largest shareholder, State-owned High-tech Investment Co., Ltd., holds 15.61% of shares, amounting to 150,127,573 shares [2]. - Other significant shareholders include Hong Kong Central Clearing Limited with 7.41% and Xianju County Industrial Investment Development Group with 1.79% [3].